Janssen seeks EU approval for first CAR-T therapy cilta-cel
4th May 2021 Uncategorised 0Cilta-cel is an investigational CAR-T cell therapy for the treatment of relapsed/refractory multiple myeloma
More: Janssen seeks EU approval for first CAR-T therapy cilta-cel
Source: News